Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials

CONCLUSIONS: Differences exist in clinical presentation, outcomes, and molecular features in Black vs. White patients with EEC in real-world registries and RCTs. Targeted-drug development, strategies to modify social determinants, and diverse inclusion in RCTs are approaches to reduce disparities.PMID:38593674 | DOI:10.1016/j.ygyno.2024.03.026

Source: Gynecologic Oncology - April 9, 2024 Category: Cancer & Oncology Authors: Zachary A Kopelman Chunqiao Tian Jordyn Tumas Neil T Phippen Christopher M Tarney Erica R Hope Stuart S Winkler Suzanne Jokajtys Calen W Kucera John K Chan Michael T Richardson Daniel S Kapp Chad A Hamilton Charles A Leath Nathaniel L Jones Rodney P Rocco Source Type: research